Analysis of 307 cases with drug‐induced liver injury between 2010 and 2018 in Japan
Mitsuhiko Aiso(Teikyo University), Naoya Sakamoto(Chibaken Saiseikai Narashino Hospital), Kenichi Ikejima(Juntendo University), Keiji Tsuji(Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital), Yoichi Hiasa(Ehime University Hospital), Hiromasa Ohira(Fukushima Medical University), Takayoshi Ito(SHOWA Medical University), Naoya Kato(The University of Tokyo), Hajime Takikawa(Teikyo University), Ken Sato(Gunma University), Masaaki Watanabe(Kitasato University), Satoshi Mochida(Saitama Medical University), Kazuto Tajiri(Toyama University Hospital), Atsushi Tanaka(Medizinische Hochschule Hannover), Akinobu Takaki(Okayama University), Yoshiyuki Ueno(Yamagata Prefectural University of Health Sciences), Shuichi Kaneko(Kanazawa University), Hiroshi Yasuda(Japan Bio Products (Japan)), Tatehiro Kagawa(Tokai University), Shotaro Sakisaka(Fukuoka University), Yoshiyuki Takei(The Japanese Society of Gastroenterological Surgery), Etsuko Hashimoto(Tokyo Women's Medical University), Minoru Ayada(Hamamatsu University Hospital), Yasushi Matsuzaki(Tokyo Medical University), Masashi Yoneda(Aichi Medical University), Kenji Ohmoto(Kurashiki Medical Center), Takuji Torimura(Omuta hospital)
Cited by 61
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504